Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aceragen, Inc. (ACGN) vs Pasithea Therapeutics Corp. (KTTA)

Aceragen, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Aceragen, Inc. and Pasithea Therapeutics Corp. are of similar size ($17.2M and $17.1M). Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −467.5%) and the lower return on invested capital (−367.5% vs −135.4%). Across the 15 metrics below, Pasithea Therapeutics Corp. leads on 10 and Aceragen, Inc. on 5.

Valuation

Metric ACGN KTTA Biotechnology median
P/E n/m n/m 7.88
P/S 1.52 32.98 11.47
P/B 0.83 0.32 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 1.28 0.74
EV/Sales 4.09 (61.07) 10.73
Earnings yield (181.40%) (316.00%) (28.84%)
Free cash flow yield (250.88%) (109.92%) (23.03%)

Profitability

Metric ACGN KTTA Biotechnology median
Gross margin 83.46% 0.00% 65.16%
Operating margin (503.92%) 0.00% 0.00%
Net margin (467.53%) 0.00% 0.00%
Free cash flow margin (339.17%) 0.00% 0.00%
Return on equity (169.66%) (65.49%) (57.72%)
Return on assets (75.58%) (61.97%) (49.22%)
Return on invested capital (135.35%) (367.46%) 0.00%

Growth

Metric ACGN KTTA Biotechnology median
Revenue growth (TTM) 1,226.28% — 5.64%
EPS growth (last fiscal year) (121.58%) 77.07% —
Revenue growth, 5-year CAGR 81.19% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACGN KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.32 26.25 4.73
Net debt to EBITDA 0.43 2.74 0.96

Dividend

Metric ACGN KTTA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ACGN KTTA Biotechnology median
Market cap 17.15m 17.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack